This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Pharmaceuticals S.a.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Deepak Vitthal Ukride: Innovator in DPP IV Inhibitors
Introduction
Deepak Vitthal Ukride is a notable inventor based in Navi Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for Type 2 diabetes. His innovative work has led to the creation of a patent that addresses critical health issues.
Latest Patents
Deepak holds a patent for "Processes for the preparation of DPP IV inhibitors." This invention relates to novel processes for preparing DPP-IV inhibitors that are useful for the treatment of Type 2 diabetes. The patent includes the structure of formula I and pharmaceutically acceptable salts thereof, showcasing his commitment to advancing medical science.
Career Highlights
Deepak is currently employed at Glenmark Pharmaceuticals S.A., where he continues to work on innovative solutions in the pharmaceutical industry. His role at Glenmark allows him to collaborate with other talented professionals and contribute to groundbreaking research.
Collaborations
Some of his coworkers include Ashok Bhausaheb Kadam and Shantaram Kashinath Phatangare. Their collective expertise enhances the innovative environment at Glenmark Pharmaceuticals.
Conclusion
Deepak Vitthal Ukride's contributions to the field of pharmaceuticals, particularly through his patent on DPP IV inhibitors, highlight his role as an important inventor in the industry. His work not only advances medical treatments but also reflects the collaborative spirit of innovation in the pharmaceutical sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile